High Flow Nasal Prongs Use in the Post-cardiac Surgical Population Increases Functional Residual Capacity, Improves Oxygenation and Reduces Work of Breathing

Abstract

with ‘high’ dose therapy. Patients in each dose category did not demonstrate clinically meaningful differences on measures of acuity, transfusion requirements or prior medications. Results demonstrated no significant differences in the rate of thromboembolic adverse events, response to bleeding or 28-day mortality (Table 1). Discussion: These findings raise the important question of whether lower doses of rFVIIa may be as effective and efficacious as higher doses in the treatment of severe bleeding in cardiac surgery patients. doi:10.1016/j.hlc.2010.10.020 High Flow Nasal Prongs Use in the Post-cardiac Surgical Population Increases Functional Residual Capacity, Improves Oxygenation and Reduces Work of Breathing J.F. Fraser 1,∗, A. Corley1, A.G. Barnett 2, L. Caruana1, O. Tronstad1 1 Critical Care Research Group, The Prince Charles Hospital, Brisbane, Australia 2 Institute ofHealth&Biomedical Innovation,QueenslandUniversity of Technology, Brisbane, Australia Introduction: Hypoventilation, lobar collapse and atelectasis are not uncommon after cardiac surgery and may result inprolonged invasiveandnon-invasiveventilation together with the incipient ICU costs. High flow nasal p t i E w c